The comparison of epigallocatechin gallate (EGCG) and ibuprofen as adjuvants to paracetamol on interleukin-6 (IL-6) levels and pain scales in an acute pain model after femur fracture
نویسندگان
doi
10.48309/jmpcr.2026.561201.1908چکیده
Acute pain from femoral fracture, if inadequately managed, can lead to systemic and psychological complications. The cyclooxygenase (COX) pathway contributes to inflammation by releasing interleukin-6 (IL-6). Non-steroidal anti-inflammatory drugs are commonly combined with paracetamol for multimodal pain therapy, but they carry risks such as nonunion and limited efficacy. Epigallocatechin gallate (EGCG), a flavonoid with anti-inflammatory properties, may serve as an alternative analgesic adjuvant. A post-test only control group design was conducted in 28 male Wistar rats, divided into four groups: control, ibuprofen (20 mg/kg) + paracetamol (200 mg/kg), EGCG (25 mg/kg) + paracetamol (200 mg/kg), and EGCG (50 mg/kg) + paracetamol (200 mg/kg). A complete femoral fracture was surgically induced. However, one rat was excluded because it died after the femoral fracture was induced (n=27). Pain was assessed with the Von Frey test, and plasma IL-6 was measured using ELISA after 24 hours. Epigallocatechin gallate -paracetamol treatment significantly increased Von Frey thresholds compared with ibuprofen-paracetamol (p < 0.001), showing a dose-dependent effect. No significant difference in IL-6 reduction was found between Epigallocatechin gallate-paracetamol and ibuprofen-paracetamol groups (p = 0.988). IL-6 levels moderately correlated negatively with Von Frey thresholds (r = –0.491; p = 0.009). EGCG as an adjuvant to paracetamol provides superior analgesia compared with ibuprofen. Although no significant difference in IL-6 reduction was found, the anti-inflammatory effect of the EGCG-paracetamol combination equally effective to the ibuprofen-paracetamol combination in this model .